Skip to main content

Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
1.04 0.03 (2.97%)
Sep 21, 2021 2:58 PM EDT - Market open
Market Cap93.93M
Revenue (ttm)2.05M
Net Income (ttm)-67.91M
Shares Out88.69M
EPS (ttm)-0.77
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume369,637
Open1.02
Previous Close1.01
Day's Range1.01 - 1.04
52-Week Range0.93 - 3.77
Beta0.96
AnalystsBuy
Price Target3.83 (+268.3%)
Est. Earnings DateNov 4, 2021

About AGRX

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a reg...

IndustryPharmaceuticals
IPO DateMay 23, 2014
CEOAlfred Altomari
Employees28
Stock ExchangeNASDAQ
Ticker SymbolAGRX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for AGRX stock is "Buy." The 12-month stock price forecast is 3.83, which is an increase of 268.27% from the latest price.

Price Target
$3.83
(268.27% upside)
Analyst Consensus: Buy

News

Agile Therapeutics to Participate in Upcoming Investor Conferences

PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following v...

2 weeks ago - GlobeNewsWire

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorges...

PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth service, ...

1 month ago - GlobeNewsWire

2 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...

Other symbols:MINM
1 month ago - Benzinga

3 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...

Other symbols:ARCUEC
1 month ago - Benzinga

Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 4.76% and -18.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Agile Therapeutics: Q2 Earnings Insights

Shares of Agile Therapeutics (NASDAQ:AGRX) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 66.67% year over year to ($0.20), which beat the ...

1 month ago - Benzinga

Agile Therapeutics Reports Second Quarter 2021 Financial Results

Total Prescriptions (TRx) Grew 171% in Second Quarter

1 month ago - GlobeNewsWire

Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021

Live Conference Call and Webcast at 4:30 p.m. EDT Live Conference Call and Webcast at 4:30 p.m. EDT

2 months ago - GlobeNewsWire

Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference

PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the company will be participating virtually in the William Blair ...

3 months ago - GlobeNewsWire

Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 9.09% and -82.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Recap: Agile Therapeutics Q1 Earnings

Shares of Agile Therapeutics (NASDAQ:AGRX) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 100.00% year over year to ($0.20), which bea...

4 months ago - Benzinga

Agile Therapeutics Reports First Quarter 2021 Financial Results

Prescription Growth Reflects Increasing Demand for Twirla

4 months ago - GlobeNewsWire

Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradio...

PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial evaluating...

4 months ago - GlobeNewsWire

CORRECTING AND REPLACING -- Agile Therapeutics

PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read "Agile Therapeutics to Report First...

5 months ago - GlobeNewsWire

Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020

Live Conference Call and Webcast at 4:30 p.m. EDT Live Conference Call and Webcast at 4:30 p.m. EDT

5 months ago - GlobeNewsWire

7 Beaten Down Stocks with Significant Insider Buying

Insider buying could be a bullish sign for a stock. Insiders may sell their shares for many reasons.

5 months ago - InvestorPlace

7 Penny Stocks That May Have Room to Run Higher

Investors in penny stocks know the prices of many have crashed. But these seven stocks may have room to run higher.

Other symbols:AQMSCKPTHEPAIFRXLLNW
5 months ago - InvestorPlace

Agile Therapeutics to Present at Upcoming March Investor Conferences

PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will pres...

6 months ago - GlobeNewsWire

Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 13.04% and -25.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive A...

Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available

6 months ago - GlobeNewsWire

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participat...

8 months ago - GlobeNewsWire

Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthca...

9 months ago - GlobeNewsWire

Agile Therapeutics: Managing A Position Ahead Of Twirla's Launch

Agile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a $4.1B addressable market. Launching an FDA approved p...

9 months ago - Seeking Alpha

Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl est...

Once-Weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol (EE)

9 months ago - GlobeNewsWire